Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

El Nile Company for Pharmaceuticals and Chemical Industries SAE

NIPH.CA ✓ COMPLIANTFree checks used up today ☆ Track — members

The Egyptian Exchange · Healthcare · Pharmaceuticals ·

Egypt Micro Cap Analyst: N/A

Last Close

$4.82

▼ -0.93%

Market Cap $245.27M · Vol 254.66K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

52.98

FWD: N/A

Market Cap

$245.27M

Micro Cap

Div Yield

0.74%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

30.14

Momentum

Beta

0.51

vs Market

52W High

$9.36

51.99% below

52W Low

$1.57

183.94% above

Volume

254.66K

Avg 400.70K

P/B

7.66

Price-to-book

ROE

N/A

Return on equity

Free Float

20.38%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, El Nile Company for Pharmaceuticals and Chemical Industries SAE (NIPH.CA) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NIPH.CA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.82%

-22.07%

+12.92%

+112.19%

YTD

+165.92%

+96.04%

+929.41%

+3,421.41%

Financials & Valuation

TTM · Annual

Total Revenue	$43.48M
Net Income	$5.22M
Revenue Growth (YoY)	-32.74%
Gross Margin	31.68%
Operating Margin	24.96%
Net Profit Margin	12.01%
ROE	N/A
ROA · ROIC	11.32% · 13.23%

P/E Ratio	52.98
Forward P/E (FY1)	N/A
PEG Ratio	0.38
P/S	3.84
P/B	7.66
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	50.00M

Technical Indicators

50-Day SMA	$5.95
200-Day SMA	$3.41
RSI (14)	30.14
Beta	0.51
52-Week High	$9.36
52-Week Low	$1.57

Volume Today	254.66K
Avg Daily Volume (30D)	400.70K
Relative Volume	0.64x
Volatility (10D)	104.63
Volatility (30D)	76.85
Free Float	20.38%

Analyst Consensus

N/A

Current Price $4.82

Mean Target N/A

52W Low$1.57 52W High$9.36

Current

Target

$1.57 $9.36

Current Analyst target

· 0 analysts

Identifiers

ExchangeThe Egyptian Exchange

FIGIBBG001S937B6

ISINEGS38331C012

CountryEgypt

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Company +2.83% JNJ Johnson & Johnson +3.81% ABBV AbbVie Inc. +0.14% NVS Novartis AG +1.52% NOVN.S Novartis AG +1.58%

Company Profile

El Nile Company for Pharmaceuticals and Chemical Industries SAE is an Egypt-based company engaged in the pharmaceuticals sector. The Company manufactures and markets pharmaceuticals, various types of medical materials, chemical products and cosmetics, as well as surgical threads and medical solutions. The Company operates through its head office and factories in Cairo, in addition to a network of seven retail branches located across Egypt. The Company is specialized in the production of Lyophilized sterile products, effervescent granules, a range of parentrals and medicinal cosmetics. Holding Company for Pharmaceuticals (Holdipharma) holds a 66.7% stake of the Company’s capital.